Startup Funding Tracker

Avammune Therapeutics funding, investors and company details

Avammune Therapeutics is an emerging Pharmaceutical startup from Bengaluru, working in the space of biopharma startup developing small molecule drugs. Founded by Arun B Papaiah, Srinivasan Namala, Aditya Kulkarni.

• Company: Avammune Therapeutics Inc
• Sector: Pharmaceutical
• Location: Bengaluru
• Founders: Arun B Papaiah, Srinivasan Namala, Aditya Kulkarni
• Total funding raised: ₹102.64 Cr

Company overview

Avammune Therapeutics is a biopharmaceutical company developing small-molecule modulators of the innate immune system to treat cancer and autoimmune diseases. Its proprietary pipeline includes lead candidates like AVA-NP-695 (ENPP1 inhibitor) and AVA-ADR-001 (ADAR1p150 inhibitor), both in preclinical stages

Funding rounds

• Latest round (Series A): $ 12.00 Mn (₹102.64 Cr.), 2025-05-12. Investors: Capital 2B, IvyCap Ventures, 1Crowd
• Past round: Undisclosed Amount, 2022-07-15. Investors: The Chennai Angels